#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Acute pancreatitis risk after kidney transplantation: Propensity score matching analysis of a national cohort


Autoři: Ya-Wen Chuang aff001;  Shih-Ting Huang aff001;  Tung-Min Yu aff001;  Chi-Yuan Li aff004;  Mu-Chi Chung aff001;  Cheng-Li Lin aff005;  Chi-Sen Chang aff001;  Ming-Ju Wu aff001;  Chia-Hung Kao aff004
Působiště autorů: Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan aff001;  College of Medicine, China Medical University, Taichung, Taiwan aff002;  Graduate Institute of Public Health, China Medical University, Taichung, Taiwan aff003;  Graduate Institute of Biomedical Sciences and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan aff004;  Office for Health Data, China Medical University Hospital, Taichung, Taiwan aff005;  Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan aff006;  Department of Nuclear Medicine and PET Center, and Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan aff007;  Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan aff008
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0222169

Souhrn

Purpose

Data for elucidating post-kidney transplantation (KT) acute pancreatitis (AP) risk are limited and no large-scale cohort study has investigated the impact of AP after KT.

Method

Data from Taiwan National Health Insurance (NHI) Research Database (NHIRD) were calculated through the method of propensity score matching to compare the pancreatitis risk in patients with and without KT.

Results

The overall pancreatitis incidence rates were 1.71 and 0.61 per 1,000 person-years in the KT and non-KT groups, respectively and corresponding adjusted HR (aHR [95% CI]) for pancreatitis was 2.48 (1.51–4.09) in the KT group. In the multivariable model, AP risk was higher in transplant patients with alcohol-related illnesses (aHR: 3.78, 95% CI: 1.32–10.8), gall stone disease (aHR: 3.53, 95% CI: 1.48–8.44), or past history of pancreatitis (aHR: 10.3, 95% CI: 5.08–20.8). Of note, recurrent AP risk was significantly higher in the KT group (aHR: 8.19, 95% CI: 2.89–23.2). Patients with post-KT AP demonstrated shorter patient and allograft survival than did those without (both P < 0.001, respectively).

Conclusion

In conclusion, KT recipients are very likely to be associated with AP. Moreover, their inferior outcomes are strongly associated with post-KT AP.

Klíčová slova:

Medicine and health sciences – Gastroenterology and hepatology – Pancreatitis – Surgical and invasive medical procedures – Transplantation – Organ transplantation – Renal transplantation – Urinary system procedures – Endocrinology – Endocrine disorders – Metabolic disorders – Nephrology – Chronic kidney disease – Medical dialysis – Diagnostic medicine – Signs and symptoms – Hyperlipidemia – Pathology and laboratory medicine – Alcohol consumption – Research and analysis methods – Research design – Cohort studies – Biology and life sciences – Nutrition – Diet


Zdroje

1. Fagenholz PJ, Castillo CF, Harris NS, Pelletier AJ, Camargo CA Jr. Increasing United States hospital admissions for acute pancreatitis, 1988–2003. Ann Epidemiol. 2007;17:491–497. 17448682

2. Fu CY, Yeh CN, Hsu JT, Jan YY, Hwang TL. Timing of mortality in severe acute pancreatitis: experience from 643 patients. World J Gastroenterol. 2007;13:1966–1969. 17461498

3. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33:323–330. 17079934

4. Frey CF, Zhou H, Harvey DJ, White RH. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994–2001. Pancreas. 2006;33:336–344. 17079936

5. Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol. 2011;106:1697–1704. doi: 10.1038/ajg.2011.155 21577242

6. Chang MC, Su CH, Sun MS, Huang SC, Chiu CT, Chen MC, et al. Etiology of acute pancreatitis—a multi-center study in Taiwan. Hepatogastroenterology. 2003;50:1655–1657. 14571809

7. Chen HJ, Wang JJ, Tsay WI, Her SH, Lin CH, Chien CC. Epidemiology and outcome of acute pancreatitis in end-stage renal disease dialysis patients: a 10-year national cohort study. Nephrol Dial Transplant. 2017;32:1731–1736. doi: 10.1093/ndt/gfw400 28088773

8. Barbara M, Tsen A, Rosenkranz L. Acute Pancreatitis in Chronic Dialysis Patients. Pancreas. 2018;47:946–951. doi: 10.1097/MPA.0000000000001119 30113429

9. Fang JT, Huang CC, Lai MK, Chuang CK. Acute pancreatitis after renal transplantation. Br J Surg. 1989;76:1132–1135. 2597967

10. Slakey DP, Johnson CP, Cziperle DJ, Roza AM, Wittmann DH, Gray DW, et al. Management of severe pancreatitis in renal transplant recipients. Ann Surg. 1997;225:217–222. 9065299

11. Yu TM, Chuang YW, Yu MC, Chen CH, Yang CK, Huang ST, et al. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol. 2016;17:1419–1425. doi: 10.1016/S1470-2045(16)30250-9 27550645

12. Yu TM, Chuang YW, Sun KT, Yu MC, Kung SC, Lee BK, et al. Polycystic kidney disease is significantly associated with dementia risk. Neurology. 2017;89:1457–1463. doi: 10.1212/WNL.0000000000004434 28855402

13. Parsons LS, Ovation Research Group, Seattle, Washington. Performing a 1:N Case-Control Match on Propensity Score. SUGI29. 2001;165–29.


Článek vyšel v časopise

PLOS One


2019 Číslo 9
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#